Result of general meeting

June 11, 2025 biodexa pharmaceuticals plc result of general meeting biodexa pharmaceuticals plc (“biodexa” or the “company”) (nasdaq: bdrx), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs announces, announces that at its general meeting held earlier today, all four resolutions put to the company's shareholders were duly passed. the full text of, inter alia, the resolutions proposed and passed at the annual general meeting and general meeting can be found in the notice of the general meeting on the company's website at: https://biodexapharma.com/investors/corporate-governance/#agms.
GM Ratings Summary
GM Quant Ranking